Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

AUGUST 17, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. We believe the totality of the data is encouraging and supports advancing to Phase 3. Data Highlights. The live webcast can be accessed here and on the investor page of Marinus’ website. About Marinus Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. The industry also encourages the development of novel pharmaceuticals and treatments, creating opportunities for Maryland residents to access cutting-edge healthcare options.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. “Our Work with U.S.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

SEPTEMBER 8, 2021

Flora will now have the ability to quickly and efficiently reference and manage information at its cultivation and extraction facility, collect and analyze data, derive insights to find cost efficiencies, and ensure accuracy. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp.

Supply Chain 95

Supply Chain Pharmaceutical Seed-To-Sale Events 95

United Patients Group

JANUARY 4, 2024

They bridge the gap between technology and healthcare, ensuring the secure and efficient collection, storage, analysis, and utilization of patient data. They work on implementing and maintaining electronic health records (EHRs), developing data-driven solutions, and training healthcare professionals on using technology effectively.

Research and Development 52

Research and Development Patients Data Policy 52

Cannabis Law Report

OCTOBER 12, 2021

Mary Hartnett, Director of Medical Services at Sarah Lawrence College, stated, “safeCircle was our choice given the convenience of its on-site sample collection process, access to high-sensitivity RT-PCR-based testing with rapid turnaround times, ability to scale with our needs, and capacity to ease our administrative burdens.

Programs 52

Programs Clinical Trials Research and Development Therapy 52

Cannabis Law Report

JULY 20, 2021

With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”. Rahn & Associates announced today that it launched new risk management solutions for the burgeoning psychedelic medicinal industry.

Medicine 98

Medicine Business Research and Development Chronic Pain 98

PrestoDoctor

SEPTEMBER 6, 2023

One of the primary reasons for this shift is the growing acceptance and accessibility of cannabis as an alternative pain management option. Many individuals prefer the idea of using a plant-based substance rather than relying on synthetic pharmaceuticals. Medical Cannabis Access in the United States : In several U.S.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JUNE 9, 2022

Steph Sherer, Founder and President, Americans for Safe Access. Panelists: David Crawford, Senior Program Manager, Code for America. 3:15-4:15 PM: Preventing Youth Access, Promoting Consumer Safety, & Protecting Public Health in State Markets. Katie Mueller, Senior Program Manager, National Safety Council.

Policy 52

Policy Safety Seed-To-Sale Data 52

Cannabis Law Report

NOVEMBER 19, 2021

We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. Position Requirements.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Sensi Seeds

JANUARY 4, 2019

Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). Before delving further into this question, let’s consider the context in which the government implemented its medical program. Context of the Medicinal Cannabis Situation.

Medicine 75

Medicine Research and Development Patients Programs 75

Veriheal

AUGUST 31, 2020

Program between St. About Sinibaldo: Sinibaldo is an aspiring healthcare professional and a biomedical researcher in the Medical Scientist Training Program (M.D./Ph.D.) About Nishtha: Nishtha is pursuing neurology to become a physician-scientist in honor of her grandmother Nani who suffered from Alzheimer’s.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

SEPTEMBER 12, 2022

Our mushrooms are some of the most tested products on the planet as we cross the lines between Pharmaceutical, Agriculture, Botanical, and Food testing quality assays,” said Optimi Chief Science Officer, Justin Kirkland. To access a complete photo gallery of this historic grow, please click here. Penis Envy. Blue Pulaski.

History 52

History Clinical Trials Legalization Research and Development 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Conducting a Psilocybin Administration Session (20 Hours).

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

OCTOBER 21, 2021

Four in five Americans (80% ) voiced their support for a program that would make it easier to detect legal vs. illegal cannabis products. Medical cannabis programs have been adopted by nearly 40 states and increasing numbers of states are also enabling recreational or adult use programs.

Safety 52

Safety Research and Development Compliance Compliance 52

United Patients Group

MAY 17, 2023

Currently, medical cannabis is still federally illegal here in the US and not fully approved for safe and legal access in many countries around the globe. Recently, a pharmaceutical company has created a cannabis based isolate, meaning one cannabinoid, in this case CBD called Epidiolex which is available by prescription in all 50 states.

Sleep 81

Sleep Cannabinoids Patients CBD 81

Cannabis Law Report

DECEMBER 6, 2021

The Company recently presented initial data describing a methodology and findings for the successful determination of Egyptian cotton fiber, yarn and fabric origin using the combination of cotton genomics and isotopic analysis (IA) at an American Apparel and Footwear Association event. Investor Contact: Sanjay M.

Supply Chain 52

Supply Chain Therapy Research and Development Data 52

Cannabis Law Report

APRIL 26, 2022

Cultivators and brands can use this barcode to upload and access test results and compliance certifications. In addition, retailers can use it for real-time inventory management and building loyalty programs with shoppers. Lucid Green claims its data suggests the LucidID system can save retailers up $10,000 a month.

Supply Chain 52

Supply Chain Retail Strains Indica 52

Cannabis Law Report

SEPTEMBER 8, 2021

All the data points associated to tagging and testing are tracked by uploading to a secure cloud database. The CertainT platform can be used across industries such as textiles, cannabis, military, leather, fertilizer, pharmaceuticals, personal care. About Flora Growth Corp. For Applied DNA: Investor contact: Sanjay M.

Supply Chain 96

Supply Chain Therapy Pharmaceutical Food 96

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. I am thrilled to have Patricia, Steve, Julie and Dewey join us to help accelerate our capabilities across these key functions,” said Dr. Drake received her bachelor’s degree from Wichita State University and is a graduate of the Harvard Business School Executive Leadership Program.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

SEPTEMBER 2, 2021

– Company’s safeCircle™ Testing Program to Monitor for COVID-19 Among On-Campus Unvaccinated Populations –. Under the Contract, ADCL will deploy safeCircle™, its high-throughput, pooled COVID-19 testing program, to provide cost-effective COVID-19 testing. STONY BROOK, N.Y.–(BUSINESS

Clinical Trials 99

Clinical Trials Research and Development Therapy Collective 99

SpeedWeed

MARCH 2, 2021

This southern state has a large population and is embarking upon a limited license program where Georgia’s Access to Medical Cannabis Commission will bestow only six licenses. Verano chose EXPANDING BUSINESSOPPORTUNITIES IN GEORGIA and Procurement while Columbia Care’s purpose was simply Healthcare and Pharmaceuticals.

Media 52

Media Seed-To-Sale Oil Business 52

The Cannigma

JUNE 15, 2021

However, the scientific data on CBG is nowhere near as developed as what we have on CBD. For now, if you have access to quality CBD products, there’s no reason to prioritize CBG products. Easy access. Indeed, the scientific literature regarding CBD and some forms of epilepsy is rich and full of data.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Puff Puff Post

FEBRUARY 4, 2019

Tanski and other experts will meet this Friday at the Food and Drug Administration to discuss the potential role for pharmaceutical therapies and non-prescription medications such as nicotine gums and patches. Quitting smoking is notoriously difficult, even for adults with access to various aids and programs.

Vaping 101

Vaping Therapy Programs Advocacy 101

Cannabis Law Report

SEPTEMBER 23, 2019

The bill would require the Department of Justice, at a minimum, to maintain 2 multiagency Tax Recovery in the Underground Economy Criminal Enforcement Program investigative teams, formerly known as the Tax Recovery and Criminal Enforcement Task Force, in Sacramento and Los Angeles.

Legislation 40

Legislation Research and Development Programs Collective 40

Cannabis Law Report

AUGUST 3, 2021

The Contract specifies ADCL’s deployment of safeCircle™, its high-throughput, pooled COVID-19 testing program, to provide weekly asymptomatic diagnostic COVID-19 screening of on-campus unvaccinated students, staff, and faculty, and a random sampling of vaccinated individuals across the CUNY school system. Join our mailing list.

Clinical Trials 105

Clinical Trials Therapy Collective Research and Development 105

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. History of compliance with regulations and policies governing government regulated marijuana programs. Criterion 5.

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

JULY 7, 2021

Drilling down into the cannabis trademark landscape in 2018 uncovered a heavy focus on goods in Classes 34 (smokers’ articles) and 5 (medicines/pharmaceuticals), as well as Nice classes relating to food and drink products. Dutch Passion Holding BV. Source: CompuMark. Looking to the future.

Oil 71

Oil Agriculture Cannabis Food 71

Cannabis Law Report

JULY 20, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. History of compliance with regulations and policies governing government regulated marijuana programs. Criterion 5.

Law 40

Law Marijuana Education Cultivation 40

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Medicines and Healthcare products Regulatory Agency’s Innovative Licensing and Access Pathway (“ILAP”), offering the potential to accelerate time to market.

Therapy 52

Therapy Research and Development Business Access 52

The Cannigma

AUGUST 5, 2022

When antidepressants were first introduced in the mid-20 th century, they were a breakthrough in pharmaceuticals. Most existing research does not support the use of THC in combating depression and there is very limited data for other cannabinoids.” But this program offers more than just the ketamine itself.

Treatment 138

Treatment Research and Development Therapy Digestion 138

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. Eurofins CDMO is also planning to construct a new high potency Active Pharmaceutical Ingredient (API) facility, which is expected to be completed in April 2022, as well as a new large scale API plant in 2023 to accommodate increasing demand.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

AUGUST 12, 2019

For instance, when researching valuations, if your investment banker pulls down values for pharmaceutical testing labs, when he should have looked specifically at cannabis testing labs, that error could result in you leaving a substantial sum of money on the table.

Business 40

Business Banking Cannabis Concentrates 40

Cannabis Law Report

OCTOBER 12, 2021

The brand is being created to represent a focused vision towards becoming a leading house of brands with a mission to empower consumers with access and a variety of trusted cannabis packaged goods. Earlier in his career, Mr. Ripshtein oversaw business, sales and tax functions in the Canadian spirits, pharmaceutical and financial sectors.

Extraction 52

Extraction Business Hash Events 52